Engineering a Modular PapMV Nanoparticle Vaccine: Comparative Efficacy of a Covalent and a Non-Covalent N-Antigen Vaccine Against Emerging SARS-CoV-2 Variants.

Blanchette LJ, Bolduc M, Woldemariam T, Yousefi M, Rabezanahary H, Olivera-Ugarte SM, Garneau C, Angers M, Shi R, Flamand L, Baz M, Vidal S, Falzarano D, Lemay JF, Leclerc D

Open source

DOI
10.3390/vaccines14040349
Published
2026 Apr 15
Container
Vaccines
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/vaccines14040349,
  title = {Engineering a Modular PapMV Nanoparticle Vaccine: Comparative Efficacy of a Covalent and a Non-Covalent N-Antigen Vaccine Against Emerging SARS-CoV-2 Variants.},
  author = {Blanchette LJ and Bolduc M and Woldemariam T and Yousefi M and Rabezanahary H and Olivera-Ugarte SM and Garneau C and Angers M and Shi R and Flamand L and Baz M and Vidal S and Falzarano D and Lemay JF and Leclerc D},
  year = {2026},
  journal = {Vaccines},
  doi = {10.3390/vaccines14040349},
  url = {https://doi.org/10.3390/vaccines14040349}
}

RIS

TY  - JOUR
TI  - Engineering a Modular PapMV Nanoparticle Vaccine: Comparative Efficacy of a Covalent and a Non-Covalent N-Antigen Vaccine Against Emerging SARS-CoV-2 Variants.
AU  - Blanchette LJ
AU  - Bolduc M
AU  - Woldemariam T
AU  - Yousefi M
AU  - Rabezanahary H
AU  - Olivera-Ugarte SM
AU  - Garneau C
AU  - Angers M
AU  - Shi R
AU  - Flamand L
AU  - Baz M
AU  - Vidal S
AU  - Falzarano D
AU  - Lemay JF
AU  - Leclerc D
PY  - 2026
JO  - Vaccines
DO  - 10.3390/vaccines14040349
UR  - https://doi.org/10.3390/vaccines14040349
ER  - 

APA

LJ, B., M, B., T, W., M, Y., H, R., SM, O., C, G., M, A., R, S., L, F., M, B., S, V., D, F., JF, L., & D, L. (2026). Engineering a Modular PapMV Nanoparticle Vaccine: Comparative Efficacy of a Covalent and a Non-Covalent N-Antigen Vaccine Against Emerging SARS-CoV-2 Variants.. Vaccines. https://doi.org/10.3390/vaccines14040349

Source records